Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINDDS: Dexmedetomidine for Postoperative Delirium Prevention
NCT02856594Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2017
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in postoperative delirium (POD), sponsored by Massachusetts General Hospital. Started Mar 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT02856594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856594.